Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Sample size determination using an interim analysis

D R Bristol1

  • 1Schering-Plough Research Institute, Kenilworth, New Jersey 07033.

Journal of Biopharmaceutical Statistics
|September 1, 1993
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Clinical equivalence.

Journal of biopharmaceutical statistics·1999
Same author

p-value adjustments for subgroup analyses.

Journal of biopharmaceutical statistics·1997
Same author

Determining equivalence and the impact of sample size in anti-infective studies: a point to consider.

Journal of biopharmaceutical statistics·1996
Same author

Planning survival studies to compare a treatment to an active control.

Journal of biopharmaceutical statistics·1993
Same author

The analysis of failure time data in crossover studies.

Statistics in medicine·1992
Same author

Testing equality of treatment variances in a two-by-two crossover study.

Journal of biopharmaceutical statistics·1991

This study introduces a new interim analysis method for clinical trials, allowing early termination if a treatment is ineffective. This approach helps save resources and ethical considerations by stopping trials sooner when results are conclusive.

Area of Science:

  • Biostatistics
  • Clinical Trial Design
  • Statistical Inference

Background:

  • Comparative clinical trials frequently utilize interim analyses to cease studies early due to ethical or economic factors when treatment superiority is evident.
  • Existing methods often focus on demonstrating treatment superiority, with less emphasis on early termination when the null hypothesis appears true.

Purpose of the Study:

  • To propose a novel interim analysis method for one-sided hypothesis testing in comparative clinical trials.
  • To develop a procedure that allows for early trial termination when evidence suggests the null hypothesis is true.
  • To incorporate variance estimation for power control in trials that continue.

Main Methods:

  • A two-stage procedure is proposed, integrating a one-sided test for early termination.

Related Experiment Videos

  • The method is analogous to procedures designed for power independent of unknown variance.
  • Derivation of necessary constants for implementing the two-stage procedure is presented.

    • Main Results:

    • The proposed interim analysis enables early termination of clinical trials when the null hypothesis is supported.
    • The two-stage procedure facilitates variance estimation, crucial for maintaining test power if the trial proceeds.
    • Properties of the developed two-stage procedure are detailed.

    Conclusions:

    • The presented interim analysis offers a valuable tool for efficient and ethical clinical trial management.
    • This method provides a statistically sound approach to terminate trials early when treatments show no significant difference.
    • The procedure ensures robust power control even when trials are not terminated early.